|
注册号: Registration number: |
ChiCTR2200060440 |
|
最近更新日期: Date of Last Refreshed on: |
2023-03-17 21:33:51 |
|
注册时间: Date of Registration: |
2022-06-01 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
请与我们联系进一步完善测量指标信息。 略阳县18-65岁女性妇科健康现状研究 |
|
Public title: |
Research on the status of gynecological health of women aged 18-65 in Lueyang County |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
略阳县18-65岁女性妇科健康现状研究 |
|
Scientific title: |
Research on the current situation of gynecological health of women aged 18-65 in Lueyang County |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
杨思源 |
研究负责人: |
石丘玲 |
|
Applicant: |
Yang Siyuan |
Study leader: |
Shi Qiuling |
|
申请注册联系人电话: Applicant telephone: |
+86 18523676998 |
研究负责人电话:
Study leader's |
+86 18290585397 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
siyuan-yang@outlook.com |
研究负责人电子邮件: Study leader's E-mail: |
qshi@cqmu.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
重庆市渝中区医学院路1号 |
研究负责人通讯地址: |
重庆市渝中区医学院路1号 |
|
Applicant address: |
1 Yixueyuan Road, Yuzhong District, Chongqing |
Study leader's address: |
1 Yixueyuan Road, Yuzhong District, Chongqing |
|
申请注册联系人邮政编码: Applicant postcode: |
400016 |
研究负责人邮政编码: Study leader's postcode: |
400016 |
|
申请人所在单位: |
重庆医科大学 |
||
|
Applicant's institution: |
Chongqing Medical University |
||
|
研究负责人所在单位: |
重庆医科大学 |
||
|
Affiliation of the Leader: |
Chongqing Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2022-001 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
略阳县妇幼保健计划生育服务中心伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee in the Maternity Service Center of Lueyang Maternal and Child Health Care Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2022-04-29 00:00:00 | ||
|
伦理委员会联系人: |
赵晓维 |
||
|
Contact Name of the ethic committee: |
Zhao Xiaowei |
||
|
伦理委员会联系地址: |
陕西省汉中市略阳县妇幼保健计划生育服务中心 |
||
|
Contact Address of the ethic committee: |
Maternity Service Center of Lueyang Maternal and Child Health Care Hospital, Hanzhong, Shaanxi |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
重庆医科大学 |
||||||||||||||||||||||
|
Primary sponsor: |
Chongqing Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
重庆市渝中区医学院路1号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
1 Yixueyuan Road, Yuzhong District, Chongqing |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
超声医学工程国家重点实验室 |
||||||||||||||||||||||
|
Source(s) of funding: |
State Key Laboratory of Ultrasound in Medicine and Engineering |
||||||||||||||||||||||
|
研究疾病: |
妇科 |
||||||||||||||||||||||
|
Target disease: |
gynecology |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
流行病学研究 |
||||||||||||||||||||||
|
Study type: |
Epidemilogical research |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
横断面 |
||||||||||||||||||||||
|
Study design: |
Cross-sectional |
||||||||||||||||||||||
|
研究目的: |
通过面对面访问或电话访问填写妇科健康情况调查表,全面了解目标人群妇科健康状况及危险因素,理清高危HPV感染、宫颈癌等妇科疾病高发原因。 |
||||||||||||||||||||||
|
Objectives of Study: |
The gynecological health questionnaire was filled in through face-to-face or telephone interview to comprehensively understand the gynecological health status and risk factors of the target population, and clarify the causes of high incidence of gynecological diseases such as high-risk HPV infection and cervical cancer. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1.拒绝参与研究的患者; |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Patients who refuse to participate in the research; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2022-05-20 00:00:00至 To 2022-07-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2022-05-20 00:00:00 至 To 2022-07-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
女性 |
Gender: |
Female |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
非随机 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
non-random |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
2022-12-30,通过发表论文数据 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
2022-12-30,Published paper data |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
CRF表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
CRF format |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |